Page last updated: 2024-08-24

gemcitabine and ly 293111

gemcitabine has been researched along with ly 293111 in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adrian, TE; Ding, XZ; Hennig, R; Jovanovic, BD; Tong, WG; Witt, RC	1
Adrian, TE; Bell, RH; Ding, XZ; Hennig, R; Iwamura, T; Jovanovic, BD; Rao, SM; Segersvard, R; Talamonti, MS; Ventura, J; Ward, E	1
Brail, L; Enas, N; Eschbach, C; Hirsh, V; Jänne, PA; Oh, Y; Paz-Ares, L; von Pawel, J	1

Trials

1 trial(s) available for gemcitabine and ly 293111

Article	Year
Randomized, double-blind, phase II trial comparing gemcitabine-cisplatin plus the LTB4 antagonist LY293111 versus gemcitabine-cisplatin plus placebo in first-line non-small-cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2014, Volume: 9, Issue:1 Topics: Adiponectin; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Benzoates; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Double-Blind Method; Female; Gemcitabine; Humans; Leukotriene B4; Lung Neoplasms; Male; Middle Aged	2014

Article

Year

Randomized, double-blind, phase II trial comparing gemcitabine-cisplatin plus the LTB4 antagonist LY293111 versus gemcitabine-cisplatin plus placebo in first-line non-small-cell lung cancer.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2014, Volume: 9, Issue:1

Topics: Adiponectin; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Benzoates; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Double-Blind Method; Female; Gemcitabine; Humans; Leukotriene B4; Lung Neoplasms; Male; Middle Aged

2014

Other Studies

2 other study(ies) available for gemcitabine and ly 293111

Article	Year
Effect of LY293111 in combination with gemcitabine in colonic cancer. Cancer letters, 2004, Jul-08, Volume: 210, Issue:1 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzoates; Body Weight; Colonic Neoplasms; Deoxycytidine; Gemcitabine; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Receptors, Leukotriene B4; Transplantation, Heterologous; Tumor Cells, Cultured	2004
LY293111 improves efficacy of gemcitabine therapy on pancreatic cancer in a fluorescent orthotopic model in athymic mice. Neoplasia (New York, N.Y.), 2005, Volume: 7, Issue:4 Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Benzoates; Cell Line, Tumor; Deoxycytidine; Disease Progression; Drug Synergism; Female; Gemcitabine; Green Fluorescent Proteins; Humans; Image Processing, Computer-Assisted; Mice; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Pancreatic Neoplasms; Random Allocation; Time Factors	2005

Article

Year

Effect of LY293111 in combination with gemcitabine in colonic cancer.

Cancer letters, 2004, Jul-08, Volume: 210, Issue:1

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzoates; Body Weight; Colonic Neoplasms; Deoxycytidine; Gemcitabine; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Receptors, Leukotriene B4; Transplantation, Heterologous; Tumor Cells, Cultured

2004

LY293111 improves efficacy of gemcitabine therapy on pancreatic cancer in a fluorescent orthotopic model in athymic mice.

Neoplasia (New York, N.Y.), 2005, Volume: 7, Issue:4

Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Benzoates; Cell Line, Tumor; Deoxycytidine; Disease Progression; Drug Synergism; Female; Gemcitabine; Green Fluorescent Proteins; Humans; Image Processing, Computer-Assisted; Mice; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Pancreatic Neoplasms; Random Allocation; Time Factors

2005